Assisted Reproductive Technology (ART) Market: An Overview
According to a market analysis report by Reports and
Data, the Assisted
Reproductive Technology (ART) market is forecast to surpass USD 50.71 Billion by 2027. Assisted reproductive technology (ART) is
infertility treatment which involves laboratory fusion of ovule extracted from
the women’s ovaries with the male sperms. Within the recent decades
there has been a dramatic rise within the number of couples who are choosing to conceive after the age of 35. This progression
started with rise of feminism and women stepping
out of
their solely domestic roles. Today, 15% of birth-giving people are 35 and
older, up from 11% in 2002 and eight percent
in 1990. With
prevalent trend of delayed pregnancies across different parts of the
planet and therefore the use of ovulation test kits is anticipated to
grow significantly, thus stimulating the assisted reproductive technology (ART)
market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1402
Assisted
Reproductive Technology (ART) Market Dynamics
Assisted
reproductive technology (ART) are often wont to bypass fertility
problems while conserving the genetic connection. 1.5 million assisted
reproductive technology (ART) cycles were conducted worldwide in 2012. It
should however be mentioned that nearly 76.7% of assisted
reproductive technology (ART) procedures failed, and about 23.3% were successful.
Generally, assisted reproductive technology (ART) is usually
recommended when other methods haven't been successful and
when there's various male infertility or tubal blocking.
Nearly 0.3% of all
infants are born annually through assisted reproductive technology (ART)
across the world . Growing awareness about assisted reproductive
technology and diminished discomfort around pregnancy related
disorders within the social scenario have contributed sufficient
market boost of the assisted reproductive technology market. assisted
reproductive technology (ART) statistics provided by the
planet Fertility Patterns show that, Mexico's birth rate is around 2 kids
per mother, well below the amount required to support the
present population of Mexico. Same trend has been noticed in Brazil where
the birth rate is additionally smaller, at 1.75. Costa Rica’s birth
rate is right down to 1.66. These declining fertility rates can
stimulate the expansion of assisted reproductive technology (ART).
A major limiting
factor for the market is that the stringent rules and regulations.
The transfer of several of embryos during
a single cycle increases the probabilities of multiple
births. Burdened by the increased social costs
and health risks related to multiple births, legislation or
guidelines from professional societies are introduced in many
countries. Also, moderate success rate, is predicted to act as a
restraining factor on the worldwide market within the years
ahead.
Assisted Reproductive Technology (ART)
Market: Regional Outlook
North
America dominated the market in 2019 with a share of USD 9.13 billion. In the
U.S., the amount of births dropped by over 2% over 2017-2018. Consistent
with assisted reproductive technology (ART) statistics by Center of
Disease Control and Prevention (CDC) within the U.S., over 284,385
assisted reproductive technology (ART) cycles were performed in 2017 which
resulted in over 68,000 live births. 87,535 cycles were performed for egg or
embryo banking during which the intent was to freeze all resulting
eggs or embryos for future assisted reproductive technology (ART) cycles. As
more women choose late births, egg freezing is becoming more common.
Though assisted reproductive technology (ART) remains relatively
uncommon compared to its demand, its use has doubled over the past decade.
Nearly 1.7% of all infants born within the U.S. annually are
conceived through assisted reproductive technology (ART).
The Asia Pacific region is predicted to witness substantial growth as
a result of an increased understanding of healthy lifestyles.
However, the growing rate of medical tourism is fuelling demand for assisted
reproductive technology (ART), which successively was
expected to assist regional market growth.
The market in
Europe as well as the rest of the world is predicted to witness opportunity for
expansion as people in countries including the UAE, Brazil, South
Africa , the UK, Germany, and France are delaying marriage and child
birth and sometimes facing infertility.
Assisted Reproductive Technology (ART)
Market: Key Players
• Merck KGaA (Germany)
• Cooper Surgical (Denmark)
• Fujifilm Irvine Scientific (US)
• Vitroife AB (Sweden)
• Thermo Fisher Scientific (US)
• Celmatix, Inc. (US)
• Anecova (Switzerland)
• OvaScience (US)
• Ferring Pharmaceuticals (US)
• FertiPro N.V. (Belgium)
The COVID-19 Impact on Assisted Reproductive
Technology (ART) Market:
The recent outbreak of COVID-19 has impacted the expansion of the
market as in several countries IVF or other assisted reproductive technology
(ART) procedures are being postponed or cancelled. Many studies have noted that
women trying to conceive via assisted reproductive technology (ART)
are susceptible to infection owing to lower immunity. The
restricted movements and shutdown of the ART facilities in
developed also as developing nations has resulted into reduction of
couples approaching ART. However, a plethora of gynecologists are maintaining
the array of surrogate or couples enlisted under assisted reproductive
technology (ART) procedures by using digital platform, hence after a
brief span of decline in growth, the market is estimated to grow in later phase
2021.
To identify the key trends in the industry, click on
the link below: https://www.reportsanddata.com/report-detail/assisted-reproductive-technology-art-market
Report Highlights:
·
Detailed overview of the parent market
·
Changing assisted reproductive technology (ART) market dynamics
·
In-depth assisted reproductive technology (ART) market
segmentation
·
Historical, present, and projected assisted reproductive
technology (ART) market size in terms of volume and value
·
Recent assisted reproductive technology (ART) market trends and
developments
·
Competitive landscape
·
Strategies of key players and products offered
·
Segments, sub-segments, and geographical regions exhibiting
promising growth
· A neutral perspective on assisted reproductive technology (ART) market performance
Assisted
Reproductive Technology (ART) Market: Segmentation
For
the purpose of this report, Reports and Data has segmented into the global
assisted reproductive technology (ART) market on the basis of procedure,
technology, type, end use and region:
Procedures Outlook (Revenue, USD Billion; 2017-2027)
·
Fresh
Donor
·
Fresh
Non-Donor
·
Frozen
Donor
·
Frozen
Non-Donor
·
Embryo/Egg
Banking
Technology Outlook (Revenue, USD Billion; 2017-2027)
·
In-Vitro
Fertilization (IVF)
o IVF Using Intra-Cytoplasmic Sperm Injection (ICSI)
o IVF Without Using Intra-Cytoplasmic Sperm Injection
(ICSI)
·
Pre-Implantation
Genetic Screening (PGS)
·
Frozen
Embryo Replacement (FER)
·
Others
Type Outlook (Revenue, USD Billion; 2017-2027)
·
Artificial
Insemination
·
Surrogacy
·
Ovulation
Induction
·
Others
End Use Outlook (Revenue, USD Billion; 2017-2027)
·
Fertility
Clinics
·
Hospitals
·
Clinical
Research
·
Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
·
North
America
o U.S
·
Europe
o U.K
o France
·
Asia
Pacific
o China
o India
o Japan
·
MEA
·
Latin
America
o Brazil
Read More News about Assisted Reproductive Technology (ART) Market report by Reports And Data:
Assisted Reproductive Technology (ART)
Market:- https://www.prnewswire.com/news-releases/assisted-reproductive-technology-art-market-to-reach-usd-50-71-billion-by-2027--reports-and-data-301070034.html
Assisted Reproductive Technology (ART)
Market:- https://www.globenewswire.com/news-release/2019/05/14/1823995/0/en/Assisted-Reproductive-Technology-ART-Market-To-Reach-USD-50-71-Billion-By-2026-Reports-And-Data.html
No comments:
Post a Comment